• 1. Polyhydroxylated GdDTPA-derivatives as high relaxivity magnetic resonance imaging contrast agents
  Lorenzo Tei,Alessandro Barge,Matteo Galli,Roberta Pinalli,Luciano Lattuada,Eliana Gianolio,Silvio Aime RSC Adv. 2015 5 74734
• 2. Block copolymer [(l-GluA-5-BE)-b-(l-AspA-4-BE)]-based nanoflower capsules with thermosensitive morphology and pH-responsive drug release for cancer therapy
  Chander Amgoth,Shuai Chen,Tirupathi Malavath,Guping Tang J. Mater. Chem. B 2020 8 9258
• 3. The role of the cell cycle in the cellular uptake of folate-modified poly(l-amino acid) micelles in a cell population
  Jihui Tang,Ziwei Liu,Fenqi Ji,Yao Li,Junjie Liu,Jian Song,Jun Li,Jianping Zhou Nanoscale 2015 7 20397
• 4. Naphthalimide based fluorescent organic nanoparticles in selective sensing of Fe3+ and as a diagnostic probe for Fe2+/Fe3+ transition
  Deblina Sarkar,Monalisa Chowdhury,Prasanta Kumar Das J. Mater. Chem. B 2021 9 494
• 5. Investigation of acyl transfer auxiliary-assisted glycoconjugation for glycoprotein semi-synthesis
  Kudakwashe Nyandoro,Charles M. G. Lamb,Haoran Yu,Jian Shi,Derek Macmillan Org. Biomol. Chem. 2022 20 8506

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Professional Introduction to L-Aspartic acid 4-benzyl ester (CAS No. 2177-63-1)

L-Aspartic acid 4-benzyl ester, identified by the chemical compound code CAS No. 2177-63-1, is a significant intermediate in the field of pharmaceutical chemistry and biochemical research. This compound, derived from aspartic acid, has garnered attention due to its versatile applications in synthetic organic chemistry, peptidomimetics, and drug development. The benzyl ester functionality introduces stability and reactivity that make it a valuable building block for more complex molecular architectures.

The structure of L-Aspartic acid 4-benzyl ester consists of an aspartic acid backbone with a benzyl group attached to the alpha-carboxyl position via an ester linkage. This modification enhances the solubility and reactivity of the compound, making it particularly useful in peptide synthesis and as a precursor for various pharmacologically active molecules. The ester group can be hydrolyzed under acidic or basic conditions to regenerate aspartic acid, providing a reversible handle for synthetic strategies.

In recent years, L-Aspartic acid 4-benzyl ester has been extensively studied for its role in the development of peptidomimetics—molecules designed to mimic the bioactivity of natural peptides but with improved pharmacokinetic properties. These peptidomimetics are particularly relevant in the treatment of neurological disorders, where large peptide drugs face challenges such as poor oral bioavailability and rapid degradation. The benzyl ester group facilitates the introduction of various side chains or modifications without interfering with the core structure, allowing for fine-tuning of biological activity.

One of the most compelling applications of L-Aspartic acid 4-benzyl ester is in the synthesis of protease inhibitors. Proteases are enzymes that play crucial roles in various physiological processes, and their dysregulation is associated with numerous diseases, including cancer and infectious diseases. By designing peptidomimetics that incorporate L-Aspartic acid 4-benzyl ester as a key residue, researchers can develop inhibitors that selectively target specific proteases. For instance, studies have shown that derivatives of this compound can inhibit matrix metalloproteinases (MMPs), which are involved in tissue degradation and cancer metastasis.

Advances in computational chemistry have further enhanced the utility of L-Aspartic acid 4-benzyl ester. Molecular modeling techniques allow researchers to predict how modifications to this compound will affect its binding affinity to target proteins. This has led to the discovery of novel analogs with improved potency and selectivity. For example, computational studies have identified benzyl esters of aspartic acid that exhibit high binding affinity to bacterial proteases, making them promising candidates for antibiotics.

The pharmaceutical industry has also leveraged L-Aspartic acid 4-benzyl ester in the development of vaccines and immunotherapeutics. Peptide-based vaccines often require stable carriers or adjuvants to enhance immune responses. The benzyl ester group provides a scaffold for conjugating antigens or adjuvants, improving vaccine efficacy. Additionally, this compound has been used in the synthesis of T-cell epitopes for cancer immunotherapy, where precise control over peptide structure is critical for eliciting a robust immune response.

From a synthetic chemistry perspective, L-Aspartic acid 4-benzyl ester serves as a versatile precursor for more complex molecules. The presence of both an amino group and an ester group allows for sequential functionalization via nucleophilic substitution or transesterification reactions. This flexibility has enabled the synthesis of diverse libraries of compounds for high-throughput screening (HTS) in drug discovery programs. Researchers can rapidly modify the benzyl group or introduce other functional moieties to explore new chemical space without compromising the integrity of the core aspartic acid scaffold.

Recent innovations in green chemistry have also highlighted the importance of L-Aspartic acid 4-benzyl ester as a sustainable building block. Traditional synthetic routes often involve harsh conditions or generate significant waste byproducts. However, newer methodologies employ biocatalysis or microwave-assisted synthesis to improve efficiency and reduce environmental impact. These advancements align with global efforts to promote sustainable pharmaceutical manufacturing while maintaining high standards of quality and purity.

The role of L-Aspartic acid 4-benzyl ester extends beyond small-molecule drug development into materials science and biotechnology. For instance, it has been used in the design of smart polymers that respond to biological stimuli, such as pH changes or enzymatic activity. These polymers have potential applications in drug delivery systems where controlled release is essential for therapeutic efficacy.

In conclusion, L-Aspartic acid 4-benzyl ester (CAS No. 2177-63-1) is a multifaceted compound with broad applications across pharmaceuticals, biotechnology, and materials science. Its unique structural features make it an indispensable tool for synthetic chemists and biologists alike. As research continues to uncover new methodologies and applications, this compound will undoubtedly remain at the forefront of scientific innovation.

• 79338-14-0((4R)-4-Amino-5-oxo-5-phenylmethoxypentanoic Acid)
• 2578-33-8(H-D-Glu(obzl)-OH)
• 2791-79-9(Dibenzyl L-Aspartate)
• 13030-09-6(H-Glu-Obzl)
• 59-92-7(L-DOPA)
• 62965-20-2((2S)-2-amino-4-(benzyloxy)butanoic acid)
• 79337-40-9(1-Benzyl D-Aspartate)
• 7362-93-8(L-Aspartic acid 1-benzyl ester)
• 25014-27-1(Glutamic acid gamma-benzyl ester polymer)
• 4079-61-2(dibenzyl 2-aminosuccinate)